Cellular Adjuvants for Viral Infection
US-2024299521-A1 · Sep 12, 2024 · US
US9700616B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9700616-B2 |
| Application number | US-201615076776-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 22, 2016 |
| Priority date | Dec 3, 2009 |
| Publication date | Jul 11, 2017 |
| Grant date | Jul 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An improved method for the manufacture of an oil-in-water emulsion comprises using a microfluidisation device whose interaction chamber comprises a plurality of Z-type channels upstream of a back pressure chamber.
Opening claim text (preview).
The invention claimed is: 1. A microfluidization apparatus for microfluidizing a first oil-in-water emulsion to produce a second oil-in-water emulsion, said apparatus comprising an interaction chamber, at least one intensifier pump, and a back pressure chamber, wherein: the interaction chamber comprises a plurality of Z-type geometry channels, the back pressure chamber comprises a plurality of fixed geometry channels and is located downstream of the interaction chamber, wherein said back pressure chamber is configured to reduce the average oil droplet size and/or the number of oil droplets with a size >1.2 μm in an emulsion that enters the back pressure chamber from the interaction chamber and exits from the back pressure chamber thereby producing the second emulsion; and the oil-in-water emulsions comprise squalene and water. 2. The microfluidization apparatus according to claim 1 , wherein the second emulsion has an average oil droplet size of 500 nm or less. 3. The microfluidization apparatus according to claim 2 , wherein the oil-in-water emulsion further comprises polysorbate 80, and sorbitan trioleate. 4. The microfluidization apparatus of claim 1 , wherein the interaction chamber provides a shear rate in excess of 1×10 6 s −1 . 5. The microfluidization apparatus according to claim 1 , wherein the pressure of the emulsion components at the entrance to the interaction chamber is substantially constant for at least 85% of the time during which the emulsion is feed into the microfluidization apparatus.
Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers · CPC title
Orthomyxoviridae, e.g. influenza virus · CPC title
Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10) · CPC title
Emulsions, e.g. Freund's adjuvant, MF59 · CPC title
characterised by the immunostimulating additives, e.g. chemical adjuvants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.